Insider Transactions in Q1 2022 at Staar Surgical CO (STAA)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 21
2022
|
James E Francese Sr. VP, Comm. Ops., NA, APAC |
SELL
Open market or private sale
|
Direct |
922
-1.58%
|
$68,228
$74.62 P/Share
|
|
Mar 14
2022
|
James E Francese Sr. VP, Comm. Ops., NA, APAC |
SELL
Open market or private sale
|
Direct |
289
-0.49%
|
$18,496
$64.18 P/Share
|
|
Mar 07
2022
|
Scott D Barnes Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,991
+20.33%
|
-
|
|
Mar 07
2022
|
Hans Martin Blickensdoerfer Sr. VP, Comm. Ops, China |
BUY
Exercise of conversion of derivative security
|
Direct |
5,910
+6.64%
|
-
|
|
Mar 07
2022
|
James E Francese Sr. VP, Comm. Ops., NA, APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
5,839
+9.08%
|
-
|
|
Mar 07
2022
|
Samuel J Gesten Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,216
+17.17%
|
-
|
|
Mar 07
2022
|
Keith Holliday Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,716
+24.0%
|
-
|
|
Mar 07
2022
|
Caren L Mason President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,269
+19.51%
|
-
|
|
Mar 07
2022
|
Patrick F. Williams Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,225
+20.93%
|
-
|